Clearstead Advisors, LLC Sutro Biopharma, Inc. Transaction History
Clearstead Advisors, LLC
- $6.94 Billion
- Q2 2025
A detailed history of Clearstead Advisors, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 121 shares of STRO stock, worth $111. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121Holding current value
$111% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
106Shares Held
59.2MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.36 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$5.97 Million0.16% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$4.68 Million0.43% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$4.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$3.79 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $48M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...